Publication | Open Access

HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies

New OpportunitiesGliomaMedicineTargeted TherapiesAnti-cancer AgentTumor SuppressorCancer TreatmentRadiation OncologyCancer BiologyCell BiologyTumor BiologyHuman Glioblastoma